Clinical Hematology and Research

Home / Browse Journals & Books / Clinical Hematology and Research / Archive / Volume 4, Issue 1

Table of Content: Volume 4, Issue 1

Select All | |

Original Article Pages 55-58

Relationship of Transfusion Amounts to Old Age and Survival of Adult Acute Leukemia Patients Who Survived beyond 100 Days

Authors: Jeong-Shi Lin, Jia-Ching Lin, Ying-Ju Chen, Sheng-Hsuan Chien, Chun-Yu Liu and Tzeon-Jye Chiou

Abstract: The ageing process puts the elderly at risk of developing anemia and thrombocytopenia with increased risk of transfusions. Patients with increased transfusion requirements may be at increased risk of dying because of the clinical conditions which necessitate transfusion.

| | |

Research Article Pages 47-54

Neutrophil to Lymphocite Ratio Predicts Overall Survival in Newly Diagnosed Hodgkin Lymphoma Patients-Single Centre Experience

Authors: Jelena Hajder, Natasa Stanisavljević, Dragomir Marisavljević, Olivera Marković, Radmila Zivković and Vladimir Jurišić

Abstract: This retrospective analysis included 83 newly diagnosed patients with HL followed up from 2001-2015. ROC curve analysis was used to determine the optimal cut-off values for overall survival. Univariate and multivariate analysis was performed using the Cox proportional hazards regression to identify significant independent prognostic factors.

| | |

Case Report Pages 42-46

Acquired Amegakaryocytic Thrombocytopenic Purpura that Presented as Cyclic Thrombocytopenia Associated with Anti- Phospholipid Antibody Syndrome

Authors: Yoko Katsuragawa-Taminishi, Daisuke Ide, Saori Maegawa-Matsui, Shin-ichi Fuchida, Mayumi Hatsuse, Satoshi Murakami, Junya Kuroda and Chihiro Shimazaki

Abstract: A 52-year-old female, who had been taking prednisolone (PSL) for anti-phospholipid antibody syndrome (APS), was admitted to our hospital because of repeated nasal bleeding, purpura and petechiae of the extremities, and a platelet count of 7,000/μL. The PSL dose was increased due to a tentative diagnosis of idiopathic thrombocytopenic purpura (ITP), but she presented with cyclic thrombocytopenia independent of the PSL dose and repeated nasal

| | |

Publish with Scholars.Direct

Track your Manuscript Status

(Please write to editorialoffice@scholars.direct in case of any technical error)